AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1415377
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human erythropoietin (r‐HuEPO) treatment at Hb 12 g/dl
Trial: 30589600
Drug: Degarelix 240
RxNorm normalized name: Degarelix
DrugBank: Degarelix (DB06699)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Degarelix 240 mg (day 1 of cycle 1) then 80 mg (day 1 of cycles 2-6) plus letrozole 2.5 mg/day
Trial: 7957521
Drug: Intravenous colchicine
RxNorm normalized name: Colchicine
DrugBank: Colchicine (DB01394)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous colchicine (elderly subjects)
Trial: 27829249
Drug: Decoy receptor
RxNorm normalized name: NF-kappaB Decoy
DrugBank: NF-kappaB Decoy (DB05559)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Decoy receptor 3 (DcR3)
Trial: 16181608
Drug: Physical exercise
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical exercise therapy
Trial: 24837064
Drug: Hypnotic Analgesia
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic Analgesia (HA)
Trial: 31886828
Drug: Petrolatum intranasal
RxNorm normalized name: Petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Petrolatum intranasal ointment and nonmedicated soap cloths (placebo)
Trial: 29588972
Drug: Lacosamide 400
RxNorm normalized name: Lacosamide
DrugBank: Lacosamide (DB06218)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lacosamide 400 mg/day
Trial: 16632815
Drug: Intravenous ondansetron
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ondansetron (4 mg)
Trial: 25914474
Drug: Lamivudine (LAM)
RxNorm normalized name: Lamivudine
DrugBank: Lamivudine (DB00709)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lamivudine (LAM) 100 mg daily for 48 weeks
Trial: 19169651
Drug: Levetiracetam (LEV)
RxNorm normalized name: Levetiracetam
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levetiracetam (LEV) therapy initiated within 24 hours of surgery
Trial: 19169651
Drug: Phenytoin (PHT)
RxNorm normalized name: Phenytoin
DrugBank: Phenytoin (DB00252)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenytoin (PHT) therapy continued
Trial: 11515348
Drug: Lansoprazole intact
RxNorm normalized name: Lansoprazole
DrugBank: Lansoprazole (DB00448)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lansoprazole intact capsule (30 mg orally)
Trial: 19939872
Drug: Org 26828
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 26828 at doses higher than 1 μg/kg
Trial: 19939872
Drug: Org 26828
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 26828 at doses up to 0.3 μg/kg
Trial: 10963459
Drug: Oral ascorbate
RxNorm normalized name: ascorbate
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ascorbate treatment; specific dosage and duration not mentioned.
Trial: 22123096
Drug: Oral 9-THC
RxNorm normalized name: delta-9-THC
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral 9-THC maintenance
Trial: 25803777
Drug: Zinc sulfate
RxNorm normalized name: Zinc Sulfate
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc sulfate 50 mg in 10 cc, self-administered 3 times daily at meal times
Trial: 2143593
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide (360 micrograms total, 60 micrograms into each nostril, repeated twice at 15 min intervals)
Trial: 9389922
Drug: Granisetron plus
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron plus dexamethasone (20 mg i.v.)
Trial: 26892135
Drug: Icosabutate 600
RxNorm normalized name: Ethyl icosapentate
DrugBank: Icosapent ethyl (DB08887)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Icosabutate 600 mg once daily
Trial: 20863419
Drug: Control tablet
RxNorm normalized name: Daily-Vite Weight Control Tablet
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control tablet administered twice a day.
Trial: 11553203
Drug: Post-prandial insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Post-prandial insulin lispro (PL)
Trial: 28982159
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for hypertension
Trial: 7985893
Drug: Cerezyme (imiglucerase)
RxNorm normalized name: imiglucerase Injection [Cerezyme]
DrugBank: Imiglucerase (DB00053)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Cerezyme (imiglucerase) infused every 2 weeks for 9 months at a dose of 60 U/kg body weight
Trial: 24090538
Drug: Nurse-administered educational
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nurse-administered educational intervention about MRSA prevention
Trial: 26853953
Drug: Intensive medical
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive medical therapy (IMT) alone
Trial: 8072258
Drug: Progressive tapering
RxNorm normalized name: mitapivat
DrugBank: Mitapivat (DB16236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Progressive tapering of CsA after prolonged remission of more than one year
Trial: 28355039
Drug: Elevated vacuum
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elevated vacuum suspension (EVS)
Trial: 1979462
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy of neuroleptics and antidepressants
Trial: 1485367
Drug: Chronic dosing
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic dosing of ibuprofen
Trial: 31714986
Drug: Bempedoic acid
RxNorm normalized name: bempedoic acid
DrugBank: Bempedoic acid (DB11936)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Bempedoic acid (180 mg)
Trial: 21562484
Drug: Ketanserin 50
RxNorm normalized name: ketanserin
DrugBank: Ketanserin (DB12465)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin 50 mg - Placebo
Trial: 9642379
Drug: Low-dose magnesium
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose magnesium gluconate (3 g/day)
Trial: 19804455
Drug: Cytarabine given
RxNorm normalized name: Cytarabine
DrugBank: Cytarabine (DB00987)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Cytarabine given for 5 days combined with cyclophosphamide for 3 days and topotecan by continuous infusion for 5 days (Arm C)
Trial: 11986206
Drug: Imatinib mesylate
RxNorm normalized name: Imatinib Mesylate
DrugBank: Imatinib (DB00619)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Imatinib mesylate (300 to 1000 mg per day)
Trial: 11200306
Drug: All drug
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All drug treatment groups
Trial: 10883741
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment groups
Trial: 28017403
Drug: Immediate vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate vaccination with rVSV-ZEBOV (2×10^7 plaque-forming units administered intramuscularly)
Trial: 6859372
Drug: Preoperative serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative serum antisperm antibody titer below 512
Trial: 21173411
Drug: Unblinded echinacea
RxNorm normalized name: Echinacea
DrugBank: Echinacea (DB14240)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unblinded echinacea pills
Trial: 21173411
Drug: Blinded echinacea
RxNorm normalized name: Echinacea
DrugBank: Echinacea (DB14240)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blinded echinacea pills
Trial: 21173411
Drug: Open-label echinacea
RxNorm normalized name: Echinacea
DrugBank: Echinacea (DB14240)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open-label echinacea pills
Trial: 31785463
Drug: Oral trofosfamide
RxNorm normalized name: trofosfamide
DrugBank: Trofosfamide (DB12902)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral trofosfamide (arm B)
Trial: 31337325
Drug: Behavioral Activation
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral Activation Therapy
Trial: 24957950
Drug: Intradermal vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal vaccination (Intanza)
Trial: 21393260
Drug: Graded running
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Graded running programme with additional shockwave therapy (ESWT)
Trial: 22132711
Drug: 4-mg intravitreal
RxNorm normalized name: ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 4-mg intravitreal injections of triamcinolone acetonide (IVTA); 21 patients in the IVTA group
Trial: 3125788
Drug: Fleroxacin 100
RxNorm normalized name: fleroxacin
DrugBank: Fleroxacin (DB04576)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fleroxacin 100 mg intravenous infusion
Trial: 1773780
Drug: CBZ 400
RxNorm normalized name: CBZ
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CBZ 400 mg
Trial: 24092978
Drug: Rivastigmine 18
RxNorm normalized name: Rivastigmine
DrugBank: Rivastigmine (DB00989)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Rivastigmine 18 mg patch without domperidone (RWOD)
Trial: 28729021
Drug: Ceritinib 450
RxNorm normalized name: Ceritinib
DrugBank: Ceritinib (DB09063)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ceritinib 450 mg with food
Trial: 8034208
Drug: Postoperative radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative radiation therapy (3000 cGy)
Trial: 3914180
Drug: Vitamin B-6
RxNorm normalized name: Vitamin B-6 100mg Tablet
DrugBank: Pyridoxine (DB00165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin B-6 100 mg daily
Trial: 23910233
Drug: One-third dose
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One-third dose BCG
Trial: 12087932
Drug: Gel subgroup
RxNorm normalized name: RSV subgroup A stabilized prefusion F protein
DrugBank: Recombinant stabilized RSV A prefusion F antigen (DB18713)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gel subgroup (EP)
Trial: 1831533
Drug: Intratumoral injection
RxNorm normalized name: bimatoprost
DrugBank: Bimatoprost (DB00905)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intratumoral injection of OK‐432
Trial: 8454328
Drug: CMR vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CMR vaccine 240 micrograms
Trial: 26304466
Drug: Aspirin 81
RxNorm normalized name: aspirin 81 MG
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 81 mg/d
Trial: 21342412
Drug: Saxagliptin +
RxNorm normalized name: Saxagliptin
DrugBank: Saxagliptin (DB06335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saxagliptin + Metformin
Trial: 26431650
Drug: Human Urinary
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human Urinary Kallikrein injection (0.15 PNA unit) plus 100 mL saline, intravenous infusion, once a day for 14 days
Trial: 21829006
Drug: IT peribulbar
RxNorm normalized name: IT-139
DrugBank: IT-139 (DB17145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IT peribulbar injection
Trial: 28560853
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (gefitinib combined with pemetrexed and carboplatin)
Trial: 28984632
Drug: Allopurinol 600
RxNorm normalized name: Allopurinol
DrugBank: Allopurinol (DB00437)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Allopurinol 600 mg orally administered on the day before PCI and on the day of PCI
Trial: 22853642
Drug: Unstructured physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unstructured physical activity (UPA) - 30 min supervised unstructured free playtime, twice daily
Trial: 21275922
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive (OC) treatment during the active hormone phase (OC phase)
Trial: 28844193
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy with dabigatran (110 mg twice daily)
Trial: 8528053
Drug: All dose
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All dose groups
Trial: 11485375
Drug: L-NMMA alone
RxNorm normalized name: L-NMMA
DrugBank: Tilarginine (DB11815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NMMA alone
Trial: 21214718
Drug: 6-month intervention
RxNorm normalized name: leuprolide
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-month intervention program (cycle ergometer training twice a day for 5 days a week and a hypocaloric diet)
Trial: 3691273
Drug: Intravenous cisapride
RxNorm normalized name: Cisapride
DrugBank: Cisapride (DB00604)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous cisapride
Trial: 15971275
Drug: NicQb vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NicQb vaccine
Trial: 25017924
Drug: Non-oral hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Non-oral hormone therapy (1.5 mg/day percutaneous 17β-estradiol gel or equivalent for nasal route for 3 months followed by 200 mg/day micronized progesterone by the vaginal route for 14 days during each menstrual period)
Trial: 18504612
Drug: IV ibandronic
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV ibandronic acid 6 mg infused over 15 min every 28 days
Trial: 1699443
Drug: HS-HES solution
RxNorm normalized name: HE-2200
DrugBank: HE-2200 (DB06257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HS-HES solution (72 g/l NaCl, 60 g/l HES, 2400 mosmol/l)
Trial: 21829969
Drug: Amoxicillin plus
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin plus clavulanic acid (ACG)
Trial: 9742976
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment with sulphonylureas or insulin
Trial: 18641546
Drug: Concentration-controlled MMF
RxNorm normalized name: MMF
DrugBank: Monomethyl fumarate (DB14219)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concentration-controlled MMF therapy
Trial: 20670958
Drug: Fixed-dose MMF
RxNorm normalized name: MMF
DrugBank: Monomethyl fumarate (DB14219)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose MMF therapy
Trial: 3418376
Drug: BCG therapy
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG therapy
Trial: 24816198
Drug: Quetiapine XR
RxNorm normalized name: quetiapine Extended Release Oral Tablet
DrugBank: Quetiapine (DB01224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quetiapine XR 50 mg/d
Trial: 24816198
Drug: Quetiapine XR
RxNorm normalized name: quetiapine Extended Release Oral Tablet
DrugBank: Quetiapine (DB01224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quetiapine XR 150 mg/d
Trial: 24816198
Drug: Quetiapine XR
RxNorm normalized name: quetiapine Extended Release Oral Tablet
DrugBank: Quetiapine (DB01224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quetiapine XR 300 mg/d
Trial: 2486951
Drug: Fentiazac 100
RxNorm normalized name: fentiazac
DrugBank: Fentiazac (DB13217)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentiazac 100 mg every 12 hrs for 5 days
Trial: 29141679
Drug: Intravenous oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous oxytocin (10 IU in 1 mL given slowly over 1 min)
Trial: 11065040
Drug: Once-weekly drug-in-adhesive
RxNorm normalized name: risedronate
DrugBank: Risedronic acid (DB00884)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Once-weekly drug-in-adhesive (DIA) patches
Trial: 29442239
Drug: MA 320
RxNorm normalized name: Zhi ma oil
DrugBank: Sesame oil (DB11172)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MA 320 mg/day plus celecoxib 200 mg/day
Trial: 21195592
Drug: Whole grain
RxNorm normalized name: Whole grain barley
DrugBank: Barley (DB10506)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole grain wheat sourdough bread (162.5 g)
Trial: 21195592
Drug: Refined white
RxNorm normalized name: White Petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Refined white bread (168.8 g)
Trial: 3103414
Drug: Supramaintenance infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Supramaintenance infusion (2.77 +/- 0.2 times fasting M, n = 14)
Trial: 2288833
Drug: Nifedipine R
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine R 20 mg twice daily
Trial: 1904749
Drug: Racemic ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Racemic ibuprofen (all doses)
Trial: 9934939
Drug: Testosterone therapy
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone therapy (400 mg of intramuscular testosterone cypionate biweekly for 8 weeks)
Trial: 15545185
Drug: Oral clodronate
RxNorm normalized name: Clodronic acid
DrugBank: Clodronic acid (DB00720)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral clodronate 1600 mg daily for 3 years
Trial: 22704583
Drug: Oral clodronate
RxNorm normalized name: Clodronic acid
DrugBank: Clodronic acid (DB00720)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral clodronate 1600 mg daily for 3 years (in women age 50 years or older)
Trial: 10701032
Drug: Intravenous ondansetron
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ondansetron 100 micrograms/kg at the end of surgery (Group 2)
Trial: 25293388
Drug: n-3 FA
RxNorm normalized name: n-3 fatty acids
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 FA deficient sunflower oil high oleic (7.5 ml b.i.d.)
Trial: 17050586
Drug: Azimilide 125
RxNorm normalized name: Azimilide
DrugBank: Azimilide (DB04957)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azimilide 125 mg/day
Trial: 20372991
Drug: Azithromycin capsules
RxNorm normalized name: Azithromycin Capsules
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azithromycin capsules (fasted state)
Trial: 10443654
Drug: Testosterone patch
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone patch
Trial: 21235696
Drug: Initial combination
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial combination therapy with sitagliptin and pioglitazone
Trial: 24261644
Drug: Intravenous haloperidol
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous haloperidol 2 mg/q8h
Trial: 3299566
Drug: Ambroxol 120
RxNorm normalized name: AMBROXOL
DrugBank: Ambroxol (DB06742)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ambroxol 120 mg/day
Trial: 21445604
Drug: Cold therapy
RxNorm normalized name: Deep Cold Therapy
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold therapy (COLD)
Trial: 18375270
Drug: Saline at
RxNorm normalized name: AT 10
DrugBank: Dihydrotachysterol (DB01070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline at 5 mL/hr (placebo)
Trial: 9800147
Drug: Lamotrigine 500
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine 500 mg
Trial: 16870076
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy (SLIT) with a commercial NRL extract
Trial: 11250761
Drug: Finasteride cream
RxNorm normalized name: Finasteride
DrugBank: Finasteride (DB01216)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Finasteride cream (0.25%)